V is for vaccine
  • Home
  • COVID-19
  • About
  • Products
  • Gallery
  • Tutorials
  • Donate
  • IN THE NEWS
  • Contact
  • Videos

COVID-19 VACCINE MAY OFFER ONLY SHORT-TERM PROTECTION

Based on studies and medical literature, immunity after infection from coronaviruses is usually short lived. This raises the legitimate question of the limitations in the ability for COVID-19 vaccines to create long duration of immunity as well. Now that three vaccines have been authorized for use under emergency use authorization (EUA) and are being administered, whether or not the vaccines create an appreciable amount of protection or have the ability to prevent transmission is still a big unknown. World Health Organization Chief Scientist Dr. Soumya Swaminathan has stated,  "I think that at the moment, I don’t believe we have the evidence on any of the vaccines to be confident that it’s going to prevent people from actually getting the infection and therefore passing it on." Also, Dr. Anthony Fauci has expressed concern over the "durability" of a COVID-19 vaccine stating, "it likely isn't going to be a long duration of immunity."

Given the high survival rate of COVID-19, the lack of safety data on the vaccines, the already concerning number of reports of adverse events, and the lack of data on the 
ability of the vaccine to produce adequate protection and prevent transmission, no risk to benefit ratio for the vaccine can be established at this time. 

SOURCES

Dr. Anthony Fauci says there's a chance coronavirus vaccine may not provide immunity for very long
​
Article in reference to short-term efficacy of the COVID-19 vaccine

Long-term coronavirus study suggests short-term Immunity
Study evidencing reinfection of coronavirus

Possibility of COVID-19 Illness after Vaccination
CDC on Breakthrough Infection after 
Vaccination

The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine Induced Immunity
​
Peer reviewed article on limitations in achieving immunity from COVID-19 infection and vaccine

Pfizer COVID-19 FAQs
FDA FAQ responses evidencing lack of 
efficacy data




  • Home
  • COVID-19
  • About
  • Products
  • Gallery
  • Tutorials
  • Donate
  • IN THE NEWS
  • Contact
  • Videos